Experimental Gal-3 deficient mice of dietary-induced nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) were used for elucidating the pathogenesis of NASH and liver fibrosis [90]. This evidence concerns the gene LGALS3 and metabolic dysfunction-associated steatohepatitis.